Prognostic Impact of Human Lymphocyte Antigen (HLA) Class I Expression in Patients With Breast Cancer
Anticancer Research · 2024
DOI: 10.21873/anticanres.17233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Motonobu Uchiyama und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan.
- Department of Surgery, Monbetsu General Hospital, Monbetsu, Japan.
- Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan; simahiro@sapmed.ac.jp.
- Department of Breast Oncology, Juntendo University School of Medicine, Bunkyo, Japan.
- Department of Pathology, Sapporo Medical University, Sapporo, Japan.
- Department of Breast Surgical Oncology, St. Luke's International Hospital, Chuo, Japan.
Zitieren
APA
Uchiyama, M., Shima, H., Kutomi, G., Kyuno, D., Wada, A., Kuga, Y., Tamura, Y., Hirohashi, Y., Torigoe, T., & Takemasa, I. (2024). Prognostic Impact of Human Lymphocyte Antigen (HLA) Class I Expression in Patients With Breast Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17233
Vancouver
Uchiyama M, Shima H, Kutomi G, Kyuno D, Wada A, Kuga Y, et al. Prognostic Impact of Human Lymphocyte Antigen (HLA) Class I Expression in Patients With Breast Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.17233
BibTeX
@article{Uchiyama2024,
author = {Uchiyama, Motonobu and Shima, Hiroaki and Kutomi, Goro and Kyuno, Daisuke and Wada, Asaka and Kuga, Yoko and Tamura, Yasuaki and Hirohashi, Yoshihiko and Torigoe, Toshihiko and Takemasa, Ichiro},
title = {Prognostic Impact of Human Lymphocyte Antigen (HLA) Class I Expression in Patients With Breast Cancer},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17233}
}
EUVIMED